These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 19430118)

  • 21. Vesicular Stomatitis Virus glycoprotein G carrying a tandem dimer of Foot and Mouth Disease Virus antigenic site A can be used as DNA and peptide vaccine for cattle.
    Capozzo AV; Wilda M; Bucafusco D; de los Ángeles Lavoria M; Franco-Mahecha OL; Mansilla FC; Pérez-Filgueira DM; Grigera PR
    Antiviral Res; 2011 Nov; 92(2):219-27. PubMed ID: 21889542
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A mutant of Asia 1 serotype of Foot-and-mouth disease virus with the deletion of an important antigenic epitope in the 3A protein.
    Li S; Gao M; Zhang R; Song G; Song J; Liu D; Cao Y; Li T; Ma B; Liu X; Wang J
    Can J Microbiol; 2011 Mar; 57(3):169-76. PubMed ID: 21358757
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Prime-Boost Vaccination Strategy in Cattle to Prevent Foot-and-Mouth Disease Using a "Single-Cycle" Alphavirus Vector and Empty Capsid Particles.
    Gullberg M; Lohse L; Bøtner A; McInerney GM; Burman A; Jackson T; Polacek C; Belsham GJ
    PLoS One; 2016; 11(6):e0157435. PubMed ID: 27294397
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Construction of an infectious cDNA clone derived from foot-and-mouth disease virus O/QYYS/s/06].
    Lu S; Zhao Q; Liu X; Sun Y; Ren T; Zhang G; Qi W; Zha Y; Kong L; Zhang H; Fan H; Liao M
    Sheng Wu Gong Cheng Xue Bao; 2009 Jul; 25(7):982-6. PubMed ID: 19835137
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Infection and protection responses of deletion mutants of non-structural proteins of foot-and-mouth disease virus serotype Asia1 in guinea pigs.
    Lalzampuia H; Elango S; Biswal JK; Krishnaswamy N; Selvan RPT; Saravanan P; Mahadappa P; V Umapathi ; Reddy GR; Bhanuprakash V; Sanyal A; Dechamma HJ
    Appl Microbiol Biotechnol; 2022 Jan; 106(1):273-286. PubMed ID: 34889988
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased efficacy of an adenovirus-vectored foot-and-mouth disease capsid subunit vaccine expressing nonstructural protein 2B is associated with a specific T cell response.
    Moraes MP; Segundo FD; Dias CC; Pena L; Grubman MJ
    Vaccine; 2011 Nov; 29(51):9431-40. PubMed ID: 22027486
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rapid Engineering of Foot-and-Mouth Disease Vaccine and Challenge Viruses.
    Lee SY; Lee YJ; Kim RH; Park JN; Park ME; Ko MK; Choi JH; Chu JQ; Lee KN; Kim SM; Tark D; Lee HS; Ko YJ; Seo MG; Park JW; Kim B; Lee MH; Lee JS; Park JH
    J Virol; 2017 Aug; 91(16):. PubMed ID: 28566375
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Construction of a full-length infectious cDNA clone of inter-genotypic chimeric foot-and-mouth disease virus].
    Li P; Bai X; Lu Z; Sun P; Qi G; Han C; Liu Z
    Wei Sheng Wu Xue Bao; 2012 Jan; 52(1):114-9. PubMed ID: 22489468
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recombinant human adenovirus-5 expressing capsid proteins of Indian vaccine strains of foot-and-mouth disease virus elicits effective antibody response in cattle.
    Sreenivasa BP; Mohapatra JK; Pauszek SJ; Koster M; Dhanya VC; Tamil Selvan RP; Hosamani M; Saravanan P; Basagoudanavar SH; de Los Santos T; Venkataramanan R; Rodriguez LL; Grubman MJ
    Vet Microbiol; 2017 May; 203():196-201. PubMed ID: 28619144
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immune response in guinea pigs vaccinated with DNA vaccine of foot-and-mouth disease virus O/China99.
    Guo H; Liu Z; Sun S; Bao H; Chen Y; Liu X; Xie Q
    Vaccine; 2005 May; 23(25):3236-42. PubMed ID: 15837227
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sindbis virus replicase-based DNA vaccine construct encoding FMDV-specific multivalent epitope gene: studies on its immune responses in guinea pigs.
    Dar PA; Ganesh K; Nagarajan G; Sarika S; Reddy GR; Suryanarayana VV
    Scand J Immunol; 2012 Oct; 76(4):345-53. PubMed ID: 22702835
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Marker vaccine potential of foot-and-mouth disease virus with large deletion in the non-structural proteins 3A and 3B.
    Biswal JK; Subramaniam S; Ranjan R; Sharma GK; Misri J; Pattnaik B
    Biologicals; 2015 Nov; 43(6):504-11. PubMed ID: 26260689
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic and antigenic relationship of foot-and-mouth disease virus serotype O isolates with the vaccine strain O1/BFS.
    Xu W; Zhang Z; Nfon C; Yang M
    Vaccine; 2018 Jun; 36(26):3802-3808. PubMed ID: 29776753
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Construction of recombinant yellow fever virus 17D containing 2A fragment as a vaccine vector].
    Xiaowu P; Fu WC; Guo YH; Zhang LS; Xie TP; Xinbin G
    Sheng Wu Gong Cheng Xue Bao; 2006 May; 22(3):492-8. PubMed ID: 16755933
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Attenuated Salmonella choleraesuis-mediated RNAi targeted to conserved regions against foot-and-mouth disease virus in guinea pigs and swine.
    Cong W; Jin H; Jiang C; Yan W; Liu M; Chen J; Zuo X; Zheng Z
    Vet Res; 2010; 41(3):30. PubMed ID: 20167192
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chimeric virus-like particles elicit protective immunity against serotype O foot-and-mouth disease virus in guinea pigs.
    Liu X; Fang Y; Zhou P; Lu Y; Zhang Q; Xiao S; Dong Z; Pan L; Lv J; Zhang Z; Zhang Y; Wang Y
    Appl Microbiol Biotechnol; 2017 Jun; 101(12):4905-4914. PubMed ID: 28365796
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Versatility of the adenovirus-vectored foot-and-mouth disease vaccine platform across multiple foot-and-mouth disease virus serotypes and topotypes using a vaccine dose representative of the AdtA24 conditionally licensed vaccine.
    Barrera J; Brake DA; Schutta C; Ettyreddy D; Kamicker BJ; Rasmussen MV; Bravo de Rueda C; Zurita M; Pisano M; Hurtle W; Brough DE; Butman BT; Harper BG; Neilan JG
    Vaccine; 2018 Nov; 36(48):7345-7352. PubMed ID: 30327212
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Construction and immunogenicity of a recombinant fowlpox virus containing the capsid and 3C protease coding regions of foot-and-mouth disease virus.
    Zheng M; Jin N; Zhang H; Jin M; Lu H; Ma M; Li C; Yin G; Wang R; Liu Q
    J Virol Methods; 2006 Sep; 136(1-2):230-7. PubMed ID: 16780963
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vaccine strain of O/ME-SA/Ind-2001e of foot-and-mouth disease virus provides high immunogenicity and broad antigenic coverage.
    Lee G; Hwang JH; Park JH; Lee MJ; Kim B; Kim SM
    Antiviral Res; 2020 Oct; 182():104920. PubMed ID: 32828822
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Implication of Broadly Neutralizing Bovine Monoclonal Antibodies in the Development of an Enzyme-Linked Immunosorbent Assay for Detecting Neutralizing Antibodies against Foot-and-Mouth Disease Virus Serotype O.
    Cao Y; Li K; Wang S; Fu Y; Sun P; Li P; Bai X; Zhang J; Ma X; Xing X; Zhou S; Bao H; Li D; Chen Y; Li Z; Lu Z; Liu Z
    J Clin Microbiol; 2019 Dec; 57(12):. PubMed ID: 31578261
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.